Showing 1 - 10 of 2,056
The impact of insurer competition on welfare, negotiated provider prices, and premiums in the U.S. private health care … industry is theoretically ambiguous. Reduced competition may increase the premiums charged by insurers and their payments made …
Persistent link: https://www.econbiz.de/10013076578
There is widespread agreement that the US healthcare system wastes as much as 5% of GDP, yet little consensus on what care is actually unproductive. This partly arises because of the endogeneity of patient choice of treatment location. This paper uses the effective random assignment of patients...
Persistent link: https://www.econbiz.de/10013025247
One of the most important debates among health economists in rich nations is whether advances in biotechnology will spare their health care systems from a financial crisis. We must consider that prevalence rates of chronic diseases declined during the twentieth century and that this rate of...
Persistent link: https://www.econbiz.de/10012758331
A health insurer's Medical Loss Ratio (MLR) is the share of premiums spent on medical claims. The Affordable Care Act introduced minimum MLR provisions for all health insurance sold in fully-insured commercial markets, thereby capping insurer profit margins, but not levels. While intended to...
Persistent link: https://www.econbiz.de/10012957378
Theoretical models of competition with fixed prices suggest that hospitals should compete by increasing quality of care … for diseases with the greatest profitability and demand elasticity. Most empirical evidence regarding hospital competition … within hospitals across quality measures. And second, while we replicate the standard result that greater competition leads …
Persistent link: https://www.econbiz.de/10012979347
of the individual insurance market, the Marketplaces invoke many of the principles of regulated competition including … the tools of regulated competition. We then discuss ways in which the Marketplace model deviates from the more …
Persistent link: https://www.econbiz.de/10012955448
Alan Garber and Jonathan Skinner (2008) famously conjectured that the US health care system was “uniquely inefficient” relative to other countries. We test this idea using cross-country data on prescription drug sales newly linked with an arguably objective measure of relative therapeutic...
Persistent link: https://www.econbiz.de/10012964901
This paper is the first to use the method of instrumental variables to estimate the causal impact of youth obesity on U.S. medical care costs. We examine data from the Medical Expenditure Panel Survey for 2001-2013 and instrument for child BMI using the BMI of the child's biological mother. IV...
Persistent link: https://www.econbiz.de/10012949433
Selective contracting is an increasingly popular tool for reducing health care costs, but these savings must be weighed against consumer surplus losses from restricted access. In both public and private prescription drug insurance plans, issuers utilize preferred pharmacy networks to reduce drug...
Persistent link: https://www.econbiz.de/10012913791
This paper uses a difference-in-difference framework to estimate the effects of mobile money transfer technology (MMT) on healthcare usage in the face of negative health shocks. We use survey data from 2013-16 with quarterly observations on about 1,600 households of 10 villages in the Kisumu...
Persistent link: https://www.econbiz.de/10012890465